Maria Teresa Lupo-Stanghellini
Overview
Explore the profile of Maria Teresa Lupo-Stanghellini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
670
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lazzari L, Catalano G, Bruno A, Sannipoli D, Lupo-Stanghellini M, Peccatori J, et al.
Curr Res Transl Med
. 2025 Feb;
73(2):103499.
PMID: 39923313
Graft-versus-host disease (GvHD) is a frequent cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (alloHCT) and optimal approaches for its prevention have been recently updated. Post-transplant cyclophosphamide...
2.
Diral E, Furnari G, Bruno A, Greco R, Clerici D, Marktel S, et al.
Front Oncol
. 2024 Jul;
14:1391743.
PMID: 38978738
Despite allogeneic hematopoietic stem cell transplant (allo-HCT) and the development of novel FLT3 inhibitors in both induction (midostaurin) and in the relapsed/refractory setting (gilteritinib), FLT3-ITD mutated leukemia (FLT3-ITD+ AML) still...
3.
Oerlemans S, de Rooij B, Bennink C, Bullinger L, Broijl A, DAgostino M, et al.
Haematologica
. 2024 Feb;
109(6):1956-1959.
PMID: 38299690
No abstract available.
4.
Manfredi F, Stasi L, Buonanno S, Marzuttini F, Noviello M, Mastaglio S, et al.
Sci Adv
. 2023 Dec;
9(48):eadg8014.
PMID: 38039364
To study and then harness the tumor-specific T cell dynamics after allogeneic hematopoietic stem cell transplant, we typed the frequency, phenotype, and function of lymphocytes directed against tumor-associated antigens (TAAs)...
5.
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience
Campodonico E, Xue E, Piemontese S, Chiara A, Bruno A, Scorpio G, et al.
Curr Res Transl Med
. 2023 Jun;
71(3):103400.
PMID: 37331224
Introduction: In the era of JAK inhibitors, allogeneic stem cell transplantation (HSCT) remains the only curative treatment for patients with Myelofibrosis (MF). Splenic irradiation (SI) may be used to reduce...
6.
Giglio F, Xue E, Barone A, Lorentino F, Greco R, Ruggeri A, et al.
Transplant Cell Ther
. 2023 May;
29(8):519.e1-519.e9.
PMID: 37244644
Several strategies have been explored with the attempt of improving the safety and feasibility of umbilical cord blood transplantation (UCBT) in adults. The aim of this retrospective analysis was to...
7.
Noviello M, Lorentino F, Xue E, Racca S, Furnari G, Valtolina V, et al.
Blood Adv
. 2023 Apr;
7(18):5446-5457.
PMID: 37067947
Human herpesvirus 6 (HHV-6) can reactivate after allogeneic hematopoietic stem cell transplant (allo-HSCT) and may lead to severe symptoms. HHV-6-specific immune responses after HSCT are largely unexplored. We conducted a...
8.
Rescigno M, Agrati C, Salvarani C, Giannarelli D, Costantini M, Mantovani A, et al.
Front Immunol
. 2023 Feb;
14:1104124.
PMID: 36776853
Introduction: Immunocompromised patients have been shown to have an impaired immune response to COVID-19 vaccines. Methods: Here we compared the B-cell, T-cell and neutralizing antibody response to WT and Omicron...
9.
Di Cosimo S, Lupo-Stanghellini M, Costantini M, Mantegazza R, Ciceri F, Salvarani C, et al.
Front Oncol
. 2022 Nov;
12:1002168.
PMID: 36338743
Importance: Despite people with impaired immune competence due to an underlying disease or ongoing therapy, hereinafter frail patients, are (likely to be) the first to be vaccinated, they were usually...
10.
Ardizzoia F, Lorentino F, Bruno A, Marktel S, Giglio F, Clerici D, et al.
Haematologica
. 2022 Jul;
107(11):2748-2751.
PMID: 35899390
No abstract available.